Drugs / Beclometasone/Formoterol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01656005 | Aug 2012 → Jul 2016 | chronic obstructive pulmonary disease | University of Dundee | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beclometasone/Formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01656005 ↗ |
| Route | Inhaled | “inhaled corticosteroid/long acting beta-agonist/long acting muscarinic antagonist (ICS + LABA + LAMA)” PMID 29025008 ↗ Dec 2017 |